The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 11, 2026 | Grais Linda | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | van den Broek Richard | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Moore David Scott | Director | Buy(P) | 22K | $11.53 | $250K |
| Jun 11, 2026 | Moore David Scott | Director | Grant(A) | 15K | — | $0 |
| Jun 11, 2026 | Clark Ian T | Director | Grant(A) | 15K | — | $0 |
| May 18, 2026 | Miller Richard A MD | President and CEO, Director | Buy(P) | 5K | $12.05 | $60K |
| May 18, 2026 | Miller Richard A MD | President and CEO, Director | Buy(P) | 2K | $12.01 | $23K |
| Apr 23, 2026 | Chan Andrew C. | Director | Grant(A) | 30K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 30K | $15.00 | $450K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $9.70 | $146K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $12.50 | $188K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $3.61 | $54K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $2.00 | $30K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $3.27 | $49K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $2.12 | $32K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $2.60 | $39K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $0.99 | $15K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $0.97 | $15K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $2.49 | $37K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $1.64 | $25K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | $2.74 | $41K |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 30K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Jan 28, 2026 | Thompson Peter A. | Director, 10% Owner | Option exercise(M) | 15K | — | $0 |
| Dec 4, 2025 | Lea Leiv | Chief Financial Officer | Grant(A) | 400K | — | $0 |
| Dec 4, 2025 | Arcara Jeffrey | Chief Business Officer | Grant(A) | 100K | — | $0 |
| Dec 4, 2025 | Miller Richard A MD | President and CEO, Director | Grant(A) | 1.0M | — | $0 |
| Dec 4, 2025 | Jones William Benton | See Remarks | Grant(A) | 400K | — | $0 |
| Oct 2, 2025 | Moore David Scott | Director | Grant(A) | 30K | — | $0 |
| Jun 27, 2025 | Thompson Peter A. | Director, 10% Owner | Option exercise(X) | 1.4M | $3.50 | $4.9M |
| Jun 27, 2025 | Thompson Peter A. | Director, 10% Owner | Sell(S) | 1.2M | $4.16 | $4.9M |
| Jun 27, 2025 | Thompson Peter A. | Director, 10% Owner | Option exercise(X) | 1.4M | — | $0 |
| Jun 27, 2025 | Orbimed Advisors LLC | Director, 10% Owner | Sell(S) | 1.2M | $4.16 | $4.9M |
| Jun 27, 2025 | Orbimed Advisors LLC | Director, 10% Owner | Option exercise(X) | 1.4M | $3.50 | $4.9M |
| Jun 27, 2025 | Orbimed Advisors LLC | Director, 10% Owner | Option exercise(X) | 1.4M | — | $0 |
| Jun 12, 2025 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 12, 2025 | Morrison Scott W | Director | Grant(A) | 15K | — | $0 |
| Jun 12, 2025 | Clark Ian T | Director | Grant(A) | 15K | — | $0 |
| Jun 12, 2025 | Grais Linda | Director | Grant(A) | 15K | — | $0 |
| Jun 4, 2025 | Jones William Benton | See Remarks | Option exercise(M) | 19K | $3.50 | $68K |
| Jun 4, 2025 | Jones William Benton | See Remarks | Option exercise(M) | 19K | — | — |
| May 7, 2025 | Miller Richard A MD | President and CEO, Director | Option exercise(M) | 559K | $3.50 | $2.0M |
| May 7, 2025 | Miller Richard A MD | President and CEO, Director | Option exercise(M) | 559K | — | — |
| Apr 8, 2025 | van den Broek Richard | Director | Grant(A) | 30K | — | $0 |
| Dec 20, 2024 | Miller Richard A MD | President and CEO, Director | Grant(A) | 750K | — | $0 |
| Dec 20, 2024 | Lea Leiv | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Dec 20, 2024 | Jones William Benton | See Remarks | Grant(A) | 300K | — | $0 |
| Dec 20, 2024 | Arcara Jeffrey | Chief Business Officer | Grant(A) | 50K | — | $0 |
| Jun 13, 2024 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 13, 2024 | Gould Terry P | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 13, 2024 | Morrison Scott W | Director | Grant(A) | 15K | — | $0 |
| Jun 13, 2024 | Clark Ian T | Director | Grant(A) | 15K | — | $0 |
| Jun 13, 2024 | Grais Linda | Director | Grant(A) | 15K | — | $0 |
| May 10, 2024 | Miller Richard A MD | President and CEO, Director | Gift(G) | 302K | — | $0 |
| May 6, 2024 | OrbiMed Capital GP V LLC | Director, 10% Owner | Buy(P) | 1.4M | — | — |
| May 6, 2024 | OrbiMed Capital GP V LLC | Director, 10% Owner | Buy(P) | 1.4M | $1.73 | $2.5M |
| May 6, 2024 | Thompson Peter A. | Director, 10% Owner | Buy(P) | 1.4M | — | — |
| May 6, 2024 | Thompson Peter A. | Director, 10% Owner | Buy(P) | 1.4M | $1.73 | $2.5M |
| May 6, 2024 | Miller Richard A MD | President and CEO, Director | Buy(P) | 578K | $1.73 | $999K |
| May 6, 2024 | Miller Richard A MD | President and CEO, Director | Buy(P) | 559K | — | — |
| May 6, 2024 | Jones William Benton | See Remarks | Buy(P) | 20K | $1.73 | $35K |
| May 6, 2024 | Jones William Benton | See Remarks | Buy(P) | 19K | — | — |
| Feb 28, 2024 | Arcara Jeffrey | Chief Business Officer | Grant(A) | 400K | — | $0 |
| Dec 6, 2023 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Gould Terry P | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Morrison Scott W | Director | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Clark Ian T | Director | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Grais Linda | Director | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Mitchell Edith P. | Director | Grant(A) | 15K | — | $0 |
| Dec 6, 2023 | Jones William Benton | See Remarks | Grant(A) | 200K | — | $0 |
| Dec 6, 2023 | Lea Leiv | Chief Financial Officer | Grant(A) | 200K | — | $0 |
| Dec 6, 2023 | Miller Richard A MD | President and CEO, Director | Grant(A) | 500K | — | $0 |
| Jun 15, 2023 | Mitchell Edith P. | Director | Grant(A) | 15K | — | $0 |
| Jun 15, 2023 | Grais Linda | Director | Grant(A) | 15K | — | $0 |
| Jun 15, 2023 | Morrison Scott W | Director | Grant(A) | 15K | — | $0 |
| Jun 15, 2023 | Clark Ian T | Director | Grant(A) | 15K | — | $0 |
| Jun 15, 2023 | Gould Terry P | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| Jun 15, 2023 | Thompson Peter A. | Director, 10% Owner | Grant(A) | 15K | — | $0 |
| May 15, 2023 | Grais Linda | Director | Buy(P) | 10K | $2.45 | $25K |
| Mar 31, 2023 | Miller Richard A MD | President and CEO, Director | Grant(A) | 800K | — | $0 |
| Dec 20, 2022 | Jones William Benton | See Remarks | Buy(P) | 20K | $0.79 | $16K |
| Dec 14, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 10K | $0.78 | $8K |
| Dec 14, 2022 | Lea Leiv | Chief Financial Officer | Buy(P) | 4K | $0.84 | $3K |
| Dec 13, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 50K | $0.74 | $37K |
| Dec 13, 2022 | Lea Leiv | Chief Financial Officer | Buy(P) | 30K | $0.74 | $22K |
| Sep 28, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 25K | $0.76 | $19K |
| Sep 20, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 3K | $0.82 | $2K |
| Sep 20, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 5K | $0.82 | $4K |
| Sep 20, 2022 | Miller Richard A MD | President and CEO, Director | Buy(P) | 12K | $0.81 | $10K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-14. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).